Markmann J F, Posselt A M, Bassiri H, Brayman K L, Woehrle M, Hickey W F, Silvers W K, Barker C F, Naji A
Department of Surgery, University of Pennsylvania School of Medicine, Philadelphia 19104.
Transplantation. 1991 Oct;52(4):662-7. doi: 10.1097/00007890-199110000-00016.
To investigate whether the immunologic mechanisms of autoimmune pancreatic beta-cell destruction are MHC restricted, we examined the relative vulnerability of islet allografts from a panel of MHC-compatible and -incompatible donors to autoimmune damage after transplantation to spontaneously diabetic BB recipients. To circumvent a potentially confounding allograft response to the foreign islet graft, we utilized two strategies: (1) pretransplant in vitro culture of islets to delete intraislet APCs; and (2) induction of islet donor-specific immunologic tolerance in diabetes-prone BB rats. Experiments employing organ culture to prevent rejection demonstrated that MHC-incompatible grafts were significantly less vulnerable to autoimmunity than MHC-compatible grafts. In contrast, when we used the model of immunologic tolerance to exclude rejection, both MHC-compatible and -incompatible islet grafts were equally susceptible to autoimmune damage. The reason for this discrepancy has not been defined fully but may be related to our observation that tolerant BB animals exhibit increased peripheral blood NK-cell activity. NK cells are known to be cytotoxic to islets in vitro and could play a role in a non-MHC-restricted diabetogenic response in vivo. We conclude that both MHC-restricted and nonrestricted mechanisms are capable of contributing to anti-beta-cell autoimmunity in BB rats.
为了研究自身免疫性胰岛β细胞破坏的免疫机制是否受主要组织相容性复合体(MHC)限制,我们检测了一组MHC相容和不相容供体的胰岛同种异体移植物在移植到自发性糖尿病BB受体后对自身免疫损伤的相对易感性。为了避免对异体胰岛移植物产生潜在的混淆性同种异体移植反应,我们采用了两种策略:(1)胰岛移植前体外培养以清除胰岛内的抗原呈递细胞(APC);(2)在易患糖尿病的BB大鼠中诱导胰岛供体特异性免疫耐受。采用器官培养以防止排斥反应的实验表明,MHC不相容的移植物比MHC相容的移植物对自身免疫的易感性显著降低。相反,当我们使用免疫耐受模型来排除排斥反应时,MHC相容和不相容的胰岛移植物对自身免疫损伤的易感性相同。这种差异的原因尚未完全明确,但可能与我们的观察结果有关,即耐受的BB动物外周血自然杀伤(NK)细胞活性增加。已知NK细胞在体外对胰岛具有细胞毒性,并且可能在体内非MHC限制的致糖尿病反应中起作用。我们得出结论,MHC限制和非限制机制均能够促成BB大鼠的抗β细胞自身免疫。